Biochemistry Reference Ranges: Difference between revisions

Jump to navigation Jump to search

Biochemistry Reference Ranges (view source)

Revision as of 01:50, 12 September 2023

13,018 bytes added ,  01:50, 12 September 2023
m
no edit summary
No edit summary
mNo edit summary
 
(45 intermediate revisions by the same user not shown)
Line 21: Line 21:
|'''>14 days - 1 yr'''
|'''>14 days - 1 yr'''
|'''28-45'''
|'''28-45'''
|  
|'''g/L'''
|  
|  
|-
|-
Line 27: Line 27:
|'''>1-8 yrs'''
|'''>1-8 yrs'''
|'''35-45'''
|'''35-45'''
|  
|'''g/L'''
|  
|  
|-
|-
Line 33: Line 33:
|'''>8-15 yrs'''
|'''>8-15 yrs'''
|'''37-47'''
|'''37-47'''
|  
|'''g/L'''
|  
|  
|-
|-
Line 39: Line 39:
|'''>15 yrs'''
|'''>15 yrs'''
|'''32-48'''
|'''32-48'''
|  
|'''g/L'''
|  
|  
|-
|-
Line 51: Line 51:
|'''1-10 yrs'''
|'''1-10 yrs'''
|'''80-360'''
|'''80-360'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 57: Line 57:
|'''11-16 yrs (male)'''
|'''11-16 yrs (male)'''
|'''90-450'''
|'''90-450'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 63: Line 63:
|'''11-16 yrs (female)'''
|'''11-16 yrs (female)'''
|'''80-400'''
|'''80-400'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 69: Line 69:
|'''>16-18 yrs (male)'''
|'''>16-18 yrs (male)'''
|'''60-300'''
|'''60-300'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 75: Line 75:
|'''>18 yrs'''
|'''>18 yrs'''
|'''30-150'''
|'''30-150'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 87: Line 87:
|'''female'''
|'''female'''
|'''0-30'''
|'''0-30'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 99: Line 99:
|'''>30 days - Adult'''
|'''>30 days - Adult'''
|'''11-32'''
|'''11-32'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 111: Line 111:
|'''1 month-2 yrs'''
|'''1 month-2 yrs'''
|'''20-80'''
|'''20-80'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 117: Line 117:
|'''>2-5 yrs'''
|'''>2-5 yrs'''
|'''15-60'''
|'''15-60'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 123: Line 123:
|'''>5 yrs'''
|'''>5 yrs'''
|'''10-50'''
|'''10-50'''
|  
|'''U/L'''
|  
|  
|-
|-
Line 141: Line 141:
|'''grey-zone'''
|'''grey-zone'''
|'''130-250'''
|'''130-250'''
|  
|'''pmol/L'''
|  
|  
|-
|-
Line 165: Line 165:
|'''24 hrs (day after birth)'''
|'''24 hrs (day after birth)'''
|'''<100'''
|'''<100'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 171: Line 171:
|'''48 hrs (2 days after birth)'''
|'''48 hrs (2 days after birth)'''
|'''<140'''
|'''<140'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 177: Line 177:
|'''3 days'''
|'''3 days'''
|'''<200'''
|'''<200'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 183: Line 183:
|'''4-14 days'''
|'''4-14 days'''
|'''<170'''
|'''<170'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 189: Line 189:
|'''2-6 weeks'''
|'''2-6 weeks'''
|'''3-23'''
|'''3-23'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 195: Line 195:
|'''>6 weeks'''
|'''>6 weeks'''
|'''2-20'''
|'''2-20'''
|  
|'''umol/L'''
|  
|  
|-
|-
Line 207: Line 207:
|'''>50-75 yrs'''
|'''>50-75 yrs'''
|'''<105'''
|'''<105'''
|  
|'''pmol/L'''
|  
|  
|-
|-
Line 213: Line 213:
|'''>75 yrs'''
|'''>75 yrs'''
|'''<211'''
|'''<211'''
|  
|'''pmol/L'''
|  
|  
|-
|-
Line 287: Line 287:
|'''nmol/L'''
|'''nmol/L'''
|'''0800 post dose at 2400hrs'''
|'''0800 post dose at 2400hrs'''
|-
|'''Creatinine'''
|'''<30 days
|'''20-60'''
|'''umol/L'''
|
|-
|
|'''>1 month - 2 yrs'''
|'''20-50'''
|'''umol/L'''
|
|-
|
|'''>2-4 yrs'''
|'''20-60'''
|'''umol/L'''
|
|-
|
|'''>4-6 yrs'''
|'''25-65'''
|'''umol/L'''
|
|-
|
|'''>6-10 yrs'''
|'''25-70'''
|'''umol/L'''
|
|-
|
|'''>10-15 yrs'''
|'''40-80'''
|'''umol/L'''
|
|-
|
|'''>15 yrs (male)'''
|'''50-110'''
|'''umol/L'''
|
|-
|
|'''>15 yrs (female)'''
|'''45-90'''
|'''umol/L'''
|
|-
|'''CRP'''
|
|'''<5'''
|'''mg/L'''
|
|-
|'''eGFR'''
|
|'''80-120'''
|'''mL/min/1.73m2'''
|'''GFR declines by 1mL/min/year over age 40 years'''
|-
|'''Ferritin
|'''<15 yrs'''
|'''15-150'''
|'''ug/L'''
|
|-
|
|'''>15-30 yrs (male)'''
|'''20-350'''
|'''ug/L'''
|
|-
|
|'''>15-50 yrs (female)'''
|'''20-200'''
|'''ug/L'''
|
|-
|
|'''>30 yrs (male)'''
|'''20-500'''
|'''ug/L'''
|
|-
|
|'''>50 yrs (female)'''
|'''20-350'''
|'''ug/L'''
|
|-
|'''Folate'''
|
|'''>8'''
|'''nmol/L'''
|
|-
|'''FSH'''
|'''<10 yrs'''
|'''0-6.5'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''0-6.5 (pre-pubertal)'''
|'''IU/L'''
|'''levels rise during puberty towards adult range'''
|-
|
|'''>15 yrs (female)'''
|
|
|
|-
|
|'''Follicular'''
|'''3-10'''
|'''IU/L'''
|
|-
|
|'''Mid-Cycle'''
|'''4-25'''
|'''IU/L'''
|
|-
|
|'''Luteal'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Post-Menopausal'''
|'''>20'''
|'''IU/L'''
|
|-
|
|'''Antenatal'''
|'''<1'''
|'''IU/L'''
|
|-
|
|'''Male'''
|'''2-12'''
|'''IU/L'''
|
|-
|'''GGT'''
|'''<6 months'''
|'''<150'''
|'''U/L'''
|
|-
|
|'''>6-12 months'''
|'''<50'''
|'''U/L'''
|
|-
|
|'''>1-12 yrs'''
|'''<30'''
|'''U/L'''
|
|-
|
|'''>12 yrs (male)'''
|'''10-50'''
|'''U/L'''
|
|-
|
|'''>12 yrs (female)'''
|'''10-35'''
|'''U/L'''
|
|-
|'''Glucose'''
|'''Random'''
|'''3.5-7.7'''
|'''mmol/L'''
|
|-
|
|'''Fasting'''
|'''3.5-6.0'''
|'''mmol/L'''
|
|-
|
|'''Polycose test'''
|'''<7.8'''
|'''mmol/L'''
|'''1hr post'''
|-
|'''HbA1c'''
|'''Non-diabetic'''
|'''20-40'''
|'''mmol/mol'''
|
|-
|
|'''Pre-diabetes'''
|'''41-49'''
|'''mmol/mol'''
|
|-
|
|'''Diabetes'''
|'''>49'''
|'''mmol/mol'''
|
|-
|'''IgA'''
|'''<1 yr'''
|'''0.0-0.3'''
|'''g/L'''
|
|-
|
|'''1-<3 yrs'''
|'''0.0-0.9'''
|'''g/L'''
|
|-
|
|'''3-<6 yrs'''
|'''0.3-1.5'''
|'''g/L'''
|
|-
|
|'''6-<14 yrs'''
|'''0.5-2.2'''
|'''g/L'''
|
|-
|
|'''14-<19 yrs'''
|'''0.5-2.9'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''0.4-2.3'''
|'''g/L'''
|
|-
|'''IgG'''
|'''<15 days'''
|'''3.2-14.0'''
|'''g/L'''
|
|-
|
|'''15 days - <1 yr'''
|'''2.0-7.0'''
|'''g/L'''
|
|-
|
|'''1-<4 yrs'''
|'''3.2-11.5'''
|'''g/L'''
|
|-
|
|'''4-<10 yrs'''
|'''5.4-13.6'''
|'''g/L'''
|
|-
|
|'''10-<19 yrs'''
|'''6.6-15.3'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''7.0-16.0'''
|'''g/L'''
|
|-
|'''IgM'''
|'''<15 days'''
|'''0.1-0.4'''
|'''g/L'''
|
|-
|
|'''15 days - <13 wks'''
|'''0.1-0.7'''
|'''g/L'''
|
|-
|
|'''1-<4 yrs'''
|'''3.2-11.5'''
|'''g/L'''
|
|-
|
|'''13 wks - <1 yr'''
|'''0.2-0.9'''
|'''g/L'''
|
|-
|
|'''1-<19 yrs'''
|'''0.4-1.9'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''0.4-2.3'''
|'''g/L'''
|
|-
|'''Iron'''
|'''<2 months'''
|'''10-31'''
|'''umol/L'''
|
|-
|
|'''2 months - 1 yr'''
|'''4-27'''
|'''umol/L'''
|
|-
|
|'''>1-10 yrs'''
|'''5-23'''
|'''umol/L'''
|
|-
|
|'''>10-18 yrs'''
|'''8-32'''
|'''umol/L'''
|
|-
|
|'''>18 yrs'''
|'''10-30'''
|'''umol/L'''
|
|-
|'''LDH'''
|'''<14 days'''
|'''310-1220'''
|'''IU/L'''
|
|-
|
|'''>14 days - 1 yr'''
|'''190-450'''
|'''IU/L'''
|
|-
|
|'''>1-10 yrs'''
|'''190-320'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''160-280'''
|'''IU/L'''
|
|-
|
|'''>15-18 yrs'''
|'''130-250'''
|'''IU/L'''
|
|-
|
|'''>18 yrs'''
|'''110-220'''
|'''IU/L'''
|
|-
|'''LH'''
|'''<10 yrs'''
|'''0-2.5'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''0-2.5'''
|'''IU/L'''
|'''levels rise during puberty towards adult range'''
|-
|
|'''>15 (female)'''
|
|
|
|-
|
|'''Follicular'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Mid-Cycle'''
|'''10-75'''
|'''IU/L'''
|
|-
|
|'''Luteal'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Post-Menopausal'''
|'''>15'''
|'''IU/L'''
|
|-
|
|'''Antenatal'''
|'''<1'''
|'''IU/L'''
|
|-
|
|'''Male'''
|'''2-9'''
|'''IU/L'''
|
|-
|'''Lipase'''
|
|'''10-70'''
|'''U/L'''
|
|-
|'''Magnesium
|
|'''0.6-1.2'''
|'''mmol/L'''
|
|-
|'''Oestradiol'''
|'''Follicular'''
|'''77-920'''
|'''pmol/L'''
|
|-
|
|'''Mid-Cycle'''
|'''140-2380'''
|'''pmol/L'''
|
|-
|
|'''Luteal'''
|'''77-1145'''
|'''pmol/L'''
|
|-
|
|'''Post-Menopausal'''
|'''<103'''
|'''pmol/L'''
|
|-
|
|'''Male'''
|'''<160'''
|'''pmol/L'''
|
|-
|'''Osmolality'''
|
|'''280-300'''
|'''mosm/kg'''
|
|-
|'''Phosphate'''
|'''<30 days'''
|'''1.3-2.5'''
|'''mmol/L'''
|
|-
|
|'''30 days - 1 yr'''
|'''1.2-2.2'''
|'''mmol/L'''
|
|-
|
|'''>1-4 yrs'''
|'''1.1-2.0'''
|'''mmol/L'''
|
|-
|
|'''>4-11 yrs'''
|'''1.0-2.0'''
|'''mmol/L'''
|
|-
|
|'''>11-16 yrs'''
|'''0.9-1.9'''
|'''mmol/L'''
|
|-
|
|'''>16 yrs'''
|'''0.8-1.5'''
|'''mmol/L'''
|
|-
|'''Potassium
|
|'''3.5-5.2'''
|'''mmol/L'''
|
|-
|'''Progesterone'''
|'''Follicular'''
|'''1-4'''
|'''nmol/L'''
|
|-
|
|'''Luteal'''
|'''15-100'''
|'''nmol/L'''
|
|-
|
|'''Post-Menopausal'''
|'''<4'''
|'''nmol/L'''
|
|-
|
|'''Male'''
|'''0-1'''
|'''nmol/L'''
|
|-
|'''Prolactin'''
|'''Female'''
|'''25-630'''
|'''mIU/L'''
|
|-
|
|'''Male'''
|'''55-380'''
|'''mIU/L'''
|
|-
|'''Protein (Total)'''
|'''<2 months'''
|'''45/70'''
|'''g/L'''
|
|-
|
|'''>2-12 months'''
|'''50-80'''
|'''g/L'''
|
|-
|
|'''>1-6 yrs'''
|'''55/80'''
|'''g/L'''
|
|-
|
|'''>6-11 yrs'''
|'''60-83'''
|'''g/L'''
|
|-
|
|'''>11 yrs'''
|'''64-83'''
|'''g/L'''
|
|-
|'''PSA'''
|
|'''<4.0'''
|'''ug/L'''
|
|-
|'''PTH (Intact)'''
|
|'''1.6-7.2'''
|'''pmol/L'''
|
|-
|'''Rheumatoid Factor'''
|
|'''<30'''
|'''IU/L'''
|
|-
|'''Sodium'''
|
|'''135-145'''
|'''mmol/L'''
|
|-
|'''Transferrin'''
|'''<2 months'''
|'''1.3-2.3'''
|'''g/L'''
|
|-
|
|'''>2 months - 3 yrs'''
|'''1.6-3.3'''
|'''g/L'''
|
|-
|
|'''>3 yrs'''
|'''2.0-3.5'''
|'''g/L'''
|
|-
|'''% Saturation'''
|'''Male'''
|'''20-60'''
|'''%'''
|
|-
|
|'''Female'''
|'''20-50'''
|'''%'''
|
|-
|'''hs-Troponin I'''
|'''Male'''
|'''0-34'''
|'''ng/L'''
|
|-
|
|'''Female'''
|'''0-16'''
|'''ng/L'''
|
|-
|'''TSH'''
|'''<4 days'''
|'''1.0-20.0'''
|'''mIU/L'''
|
|-
|
|'''4 days - 1 month'''
|'''0.7-16.0'''
|'''mIU/L'''
|
|-
|
|'''>1-6 months'''
|'''0.5-6.0'''
|'''mIU/L'''
|
|-
|
|'''>6 months'''
|'''0.4-4.0'''
|'''mIU/L'''
|
|-
|'''Free T4'''
|'''4 days - <1 month'''
|'''10-40'''
|'''pmol/L'''
|
|-
|
|'''1 month - <1 yr'''
|'''10-30'''
|'''pmol/L'''
|
|-
|
|'''1-<12 yrs'''
|'''11-22'''
|'''pmol/L'''
|
|-
|
|'''12 yrs and above'''
|'''12-22'''
|'''pmol/L'''
|
|-
|'''Free T3'''
|'''<12 months'''
|'''4.5-10.5'''
|'''pmol/L'''
|
|-
|
|'''1-12 yrs'''
|'''3.8-8.6'''
|'''pmol/L'''
|
|-
|
|'''>12-18 yrs'''
|'''3.7-7.7'''
|'''pmol/L'''
|
|-
|
|'''>18 yrs'''
|'''2.5-6.0'''
|'''pmol/L'''
|
|-
|'''Urea'''
|'''<1 month'''
|'''1.1-6.1'''
|'''mmol/L'''
|
|-
|
|'''>1 month - 2 yrs'''
|'''0.7-5.0'''
|'''mmol/L'''
|
|-
|
|'''>2-4 yrs'''
|'''1.1-5.0'''
|'''mmol/L'''
|
|-
|
|'''>4-6 yrs'''
|'''1.1-5.7'''
|'''mmol/L'''
|
|-
|
|'''>6-10 yrs'''
|'''1.4-5.7'''
|'''mmol/L'''
|
|-
|
|'''>10-13 yrs'''
|'''1.8-6.4'''
|'''mmol/L'''
|
|-
|
|'''>13 yrs'''
|'''3.2-7.7'''
|'''mmol/L'''
|
|-
|'''Uric Acid'''
|'''0-12 yrs'''
|'''0.08-0.34'''
|'''mmol/L'''
|
|-
|
|'''>12 yrs (male)'''
|'''0.20-0.42'''
|'''mmol/L'''
|
|-
|
|'''>12 yrs (female)'''
|'''0.15-0.36'''
|'''mmol/L'''
|
|}
{| class="wikitable"
|'''BLODD GASES'''
|'''ARTERIAL'''
|'''VENOUS'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''pH'''
|'''7.35-7.45'''
|'''7.30-7.40'''
|
|
|-
|'''pCO2'''
|'''35-45'''
|'''40-50'''
|'''mmHg'''
|
|-
|'''pO2'''
|'''75-105'''
|
|'''mmHg'''
|
|-
|'''Bicarbonate (HCO3)'''
|'''22-28'''
|'''22-32'''
|'''mmol/L'''
|
|-
|'''Standard Bicarbonate'''
|'''22-28'''
|'''22-32'''
|'''mmol/L'''
|
|-
|'''Base Excess (ABE)'''
|'''+/- 3'''
|'''+/- 3'''
|'''mmol/L'''
|
|-
|'''o2 Saturation'''
|'''97-100'''
|
|'''%'''
|
|-
|'''Carboxyhaemoglobin (COHb)'''
|'''0-1.5 (non-smoker)'''
|'''0-1.5 (non-smoker)'''
|'''%'''
|
|-
|
|'''<9 (smoker)'''
|'''<9 (smoker)'''
|'''%'''
|
|-
|'''MetHb'''
|'''0-1.5'''
|'''0-1.5'''
|'''%'''
|
|-
|'''Sodium'''
|'''135-145'''
|'''135-145'''
|'''mmol/L'''
|
|-
|'''Potassium'''
|'''3.5-5.2'''
|'''3.5-5.2'''
|'''mmol/L'''
|
|-
|'''Ionised Calcium'''
|'''1.15-1.30'''
|'''1.15-1.30'''
|'''mmol/L'''
|
|-
|'''Ionised Calcium - corrected (pH 7.4)'''
|'''1.13-1.26'''
|'''1.13-1.26'''
|'''mmol/L'''
|
|-
|'''Chloride'''
|'''95-110'''
|'''95-110'''
|'''mmol/L'''
|
|-
|'''Glucose (random)'''
|'''3.5-7.7'''
|'''3.5-7.7'''
|'''mmol/L'''
|
|-
|'''Lactate'''
|'''<2.0'''
|'''<2.0'''
|'''mmol/L'''
|
|-
|'''Anion Gap'''
|'''10-20'''
|'''10-20'''
|'''mmol/L'''
|
|-
|
|
|
|
|
|-
|'''CORD GASES'''
|'''ARTERIAL'''
|'''VENOUS'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''pH'''
|'''7.10-7.40'''
|'''7.22-7.44'''
|
|
|-
|'''pCO2'''
|'''42-74'''
|'''28-53'''
|'''mmHg'''
|
|-
|'''pO2'''
|'''6-28'''
|'''16-40'''
|'''mmHg'''
|
|-
|'''HCO3'''
|'''18-28'''
|'''17-26'''
|'''mmol/L'''
|
|-
|'''Base Excess'''
|'''-12 to +2'''
|'''-12 to +2'''
|'''mmol/L'''
|
|-
|'''Lactate'''
|'''<6.1'''
|'''<6.1'''
|'''mmol/L'''
|
|}
{| class="wikitable"
|'''Urine'''
|'''SEX/AGE'''
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''U Calcium (24hrs)'''
|
|'''2.5-7.5'''
|'''mmol/24hrs'''
|
|-
|'''U Creatinine (24hrs)'''
|'''0-6 months'''
|'''0.2-1.6'''
|'''mmol/24hrs'''
|
|-
|
|'''>6 months - 2 yrs'''
|'''0.2-2.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>2-6 yrs'''
|'''0.5-6.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>6-10 yrs'''
|'''1.5-12.6'''
|'''mmol/24hrs'''
|
|-
|
|'''>10-15 yrs'''
|'''2.0-20.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>15 yrs (male)'''
|'''9.0-18.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>15 yrs (female)'''
|'''7.0-12.5'''
|'''mmol/24hrs'''
|
|-
|'''Creatinine Clearance'''
|
|'''>1.5'''
|'''ml/sec'''
|
|-
|'''U Albumin
|
|'''<30'''
|'''mg/L'''
|
|-
|'''U Alb/Crn Ratio'''
|'''Male'''
|'''<2.5'''
|'''g(alb)/mol(Crn)'''
|
|-
|
|'''Female'''
|'''<3.5'''
|'''g(alb)/mol(Crn)'''
|
|-
|'''U Osmolality'''
|'''0-6 yrs'''
|'''50-1200'''
|'''mosm/kg'''
|
|-
|
|'''>6 yrs'''
|'''300-1200'''
|'''mosm/kg'''
|
|-
|'''U pH'''
|
|'''5-8.8'''
|
|
|-
|'''U Phosphate (24hrs)'''
|
|'''16-48'''
|'''mmol/24hrs'''
|'''dependent on diet, age, muscle mass'''
|-
|'''U Potassium (24hrs)'''
|
|'''35-100'''
|'''mmol/24hrs'''
|'''diet dependent'''
|-
|'''U Protein (24hrs)'''
|
|'''0.0-0.14'''
|'''g/24hrs'''
|
|-
|'''U Pro/Crn Ratio'''
|
|'''<22.7'''
|'''g/mol'''
|
|-
|'''U Sodium (24hrs)'''
|
|'''100-250'''
|'''mmol/24hrs'''
|'''diet dependent'''
|-
|'''U Urea (24hrs)'''
|
|'''165-580'''
|'''mmol/24hrs'''
|
|}
{| class="wikitable"
|'''LIPIDS'''
|'''SEX/AGE'''
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''Cholesterol (Total)'''
|
|'''<4.0'''
|'''mmol/L'''
|
|-
|'''HDL Cholesterol'''
|
|'''>1.0'''
|'''mmol/L'''
|
|-
|'''LDL (calculated)'''
|
|'''<2.5'''
|'''mmol/L'''
|
|-
|'''Chol/HDL Ratio'''
|
|'''<4.5'''
|
|
|-
|'''Triglyceride'''
|
|'''<1.7'''
|'''mmol/L'''
|
|}
'''Optimal lipid levels are suggested by the New Zealand Guidelines Group.'''
'''http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012'''
{| class="wikitable"
|'''DRUGS'''
|
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''Carbamazepine'''
|'''Therapeutic range'''
|'''16-50'''
|'''umol/L'''
|
|-
|'''Digoxin'''
|'''Therapeutic range'''
|'''0.6-2.0'''
|'''nmol/L'''
|'''>6 hrs post-dose'''
|-
|'''Ethanol'''
|'''Nil detected'''
|'''<2.2'''
|'''mmol/L'''
|
|-
|'''Lithium'''
|'''for prophylaxis'''
|'''0.4-0.8'''
|'''mmol/L'''
|
|-
|
|'''for acute mania'''
|'''0.8-1.2'''
|'''mmol/L'''
|
|-
|
|'''toxicity is common'''
|'''>1.2'''
|'''mmol/L'''
|'''>12 hrs post-dose'''
|-
|'''Phenytoin'''
|'''Therapeutic range'''
|'''40-80'''
|'''umol/L'''
|
|-
|'''Salicylate'''
|'''Therapeutic range'''
|'''1.5-1.8'''
|'''mmol/L'''
|
|-
|
|'''Toxic'''
|'''>3.6'''
|'''mmol/L'''
|
|-
|'''Theophylline'''
|'''Therapeutic range'''
|'''55-110'''
|'''umol/L'''
|
|-
|'''Valproate'''
|'''<6 months'''
|'''28-55'''
|'''umol/L'''
|
|-
|
|'''>6 months'''
|'''350-700'''
|'''umol/L'''
|'''not reported but widely accepted as a trough range'''
|}
|}
'''Note: Antibiotics - Gentamicin, Vancomycin and Tobramycin ranges, please refer to Pharmacy for dose and time related reference ranges.'''
'''Reference ranges have been set in agreeance with:'''
'''- The South Island Quality Assurance Group (SIQAG)'''
'''- Chemical Pathology Network New Zealand (CHEMPNNZ)'''
'''- Te Whatu Ora Hawkes Bay Chemical Pathologist'''
'''- Abbott Alinity assay specific reference ranges'''
''' - The LabNet Delphic Partners'''
'''Reference ranges reviewed August 2023'''
Retrieved from "https://hawkesbaylabmanual.co.nz/wiki/index.php/Special:MobileDiff/1215...1280"

Navigation menu